Professional Documents
Culture Documents
Practices
Short Course in Biotechnology
Steve Pondell
Director of Manufacturing, Encysive Pharmaceuticals
Principal, Integrated BioTech Solutions
August 8, 2008
Part 1:
Biotech
Regulatory Environment
What is Biotechnology?
Websters
definition:
What is Biotechnology?
Contemporary
Examples:
Genetically-engineered drugs
Genetically-engineered crops
Small to medium size life science
companies
Alternative fuels
Organisms for environmental control
Nanotechnology related to health care
Medical devices
Regulatory Environment
Foreign Agencies
Mandatory
Strongly suggested
Animal
Testing
Post-marketing
Phase 3
Marketing Application
Review
Clinical Studies
Phase 2
IND
Discovery / Screening
Phase 1
Phase 4
Typical Timelines
Discovery to Commercial
Alternate fuels
Pesticide
Environmental remediator
Medical device
Small molecule drug
Biologic drug
Generic drug
1 yr
3-5 yrs
3-5 yrs
2-5 yrs
8-10 yrs
10-12 yrs
2-3 yrs
Compliance
Clinical studies
Pre-clinical, EPA
Compliance
Guidelines
Non-mandatory
Provides acceptable ways to meet regulations
Guidelines can become regulations
Compliance
Companies self-police
Enforcement
Non-compliance
Official notification
Withholding of approvals
Withdrawal of product from market
Seizure of product
Legal action
Consent decree
Personal liability of top management
Debar
Part 2: cGMPs
current Good Manufacturing
Practices
History of FDA
Identity
Purity
Safety
Effectiveness
Potency
Of drug products
Assure that these qualities are met
Consistently
Over life of product
A. General Provisions
B. Organization and Personnel
C. Buildings and Facilities
D. Equipment
E. Control of Components and Drug Product Containers
and Closures
F. Production and Process Controls
G. Packaging and Labeling Controls
H. Holding and Distribution
I. Laboratory Controls
J. Records and Reports
K. Returned and Salvaged Drug Products
A. General Provisions
Minimum requirements
Applies to drug products
B. Organization and
Personnel
D. Equipment
Warehousing
Distribution
I. Laboratory Controls
International Harmonization
Europe
Japan
US
What is Validation?
Definition
Part of cGMPs?
CFR 210/211
CFR 820
Design qualification
Installation qualification
Operating qualification
Process qualification
Re-qualification
Facilities
Utilities
Equipment
Computer Control Systems
Test Methods
Process
Cleaning
Operators?
Protocol
Part 3:
Quality
Assurance/
Quality Control
Sigma
Sigma is a metric or mathematical/statistical term which defines
how often a process fails to meet requirements.
Six Sigma is defined as a process which produces only 3.4
product defects per million opportunities (DPMO) to produce a
defect.
DPMO or PPM
308,537 2
66,807 3
6,210 4
2335
3.4
6
Sigma Level
Six Sigma
A defined methodology for reducing process
variation and a mathematical term for
defining the number of defects produced by
a process compared to the number of
opportunities to create a defect.
DMAIC Process
Metrics
Decrease variability.
Decrease defects.
Decrease time span.
Process variability and defects are the prime
enemies of efficiency.
Time waste is different from material
waste in that time waste can never be
salvaged.
Process time traps must be identified and
removed.
Components
Drug product containers
Closures
In-process materials
Packaging and labeling
Final product
Personnel Qualifications
Personnel Qualifications
Personnel Responsibilities
Consultants
FDA-483
Warning Letter
Consent Decree